Agree rolly, one possibility is that there’s one BP who have their eye firmly on HER-Vaxx, they’re involved with the MM’s/shorters to keep the SP suppressed as much as possible & don’t mind funding/incurring losses to keep the SP suppressed until a deal is completed. As more data is released it will obviously be harder to contain the SP so a deal may not be that far away as this can’t be sustained forever.
If I were to make an offer for a very promising cancer treatment, I’d rather be negotiating with the SP around 10 cents as opposed to 50 - regardless, I’m happy to sit back & watch what unfolds . .
Ann: Imugene HER-Vaxx and CHECKVacc to be Featured at ESMO, page-54
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.8¢ | $382.1K | 7.853M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 62 | 8072405 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 668099 | 5 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |